Cargando…

Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLC

Non-small cell lung cancer (NSCLC) is one of the most malignant epithelial tumors. Studies have suggested that DNA hypermethylation of promoters and abnormal histone modifications could induce tumor suppressor genes (TSGs) downregulation in NSCLC. However, the exact mechanism of TSGs downregulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongling, Da, Dezhuan, Yu, Wenqiang, Chen, Lu, Yang, Shuai, Zhang, Baolong, Wang, Yongying, Li, Linyu, Dang, Chunyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838096/
https://www.ncbi.nlm.nih.gov/pubmed/35921230
http://dx.doi.org/10.1093/hmg/ddac185
_version_ 1784869212026568704
author Li, Hongling
Da, Dezhuan
Yu, Wenqiang
Chen, Lu
Yang, Shuai
Zhang, Baolong
Wang, Yongying
Li, Linyu
Dang, Chunyan
author_facet Li, Hongling
Da, Dezhuan
Yu, Wenqiang
Chen, Lu
Yang, Shuai
Zhang, Baolong
Wang, Yongying
Li, Linyu
Dang, Chunyan
author_sort Li, Hongling
collection PubMed
description Non-small cell lung cancer (NSCLC) is one of the most malignant epithelial tumors. Studies have suggested that DNA hypermethylation of promoters and abnormal histone modifications could induce tumor suppressor genes (TSGs) downregulation in NSCLC. However, the exact mechanism of TSGs downregulation remains unclear. In this study, we found that there is no difference in the regions of most TSGs promoters in NSCLC. Moreover, we found that there is no DNA methylation difference in the region of VILL promoter in NSCLC compared with adjacent tissue samples by pyrosequencing. We further demonstrated that VILL was markedly reactivated in A549 and H1703 cells infected with miR-26A1 lentivirus while this activation was inhibited by JQ1, an enhancer inhibitor. In addition, we identified that miR-26A1 could function as a tumor suppressor to inhibit proliferation and metastasis of NSCLC cells. Chromatin immunoprecipitation assays revealed that overexpression of miR-26A1 could significantly induce the enrichment of H3K27ac at the enhancer regions in A549 cells. To sum up, our findings revealed that enhancer-mediated TSGs regulation occured in NSCLC, suggesting that miR-26A1 could serve as a key regulator and may be a potential therapeutic target for NSCLC.
format Online
Article
Text
id pubmed-9838096
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-98380962023-01-17 Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLC Li, Hongling Da, Dezhuan Yu, Wenqiang Chen, Lu Yang, Shuai Zhang, Baolong Wang, Yongying Li, Linyu Dang, Chunyan Hum Mol Genet Original Article Non-small cell lung cancer (NSCLC) is one of the most malignant epithelial tumors. Studies have suggested that DNA hypermethylation of promoters and abnormal histone modifications could induce tumor suppressor genes (TSGs) downregulation in NSCLC. However, the exact mechanism of TSGs downregulation remains unclear. In this study, we found that there is no difference in the regions of most TSGs promoters in NSCLC. Moreover, we found that there is no DNA methylation difference in the region of VILL promoter in NSCLC compared with adjacent tissue samples by pyrosequencing. We further demonstrated that VILL was markedly reactivated in A549 and H1703 cells infected with miR-26A1 lentivirus while this activation was inhibited by JQ1, an enhancer inhibitor. In addition, we identified that miR-26A1 could function as a tumor suppressor to inhibit proliferation and metastasis of NSCLC cells. Chromatin immunoprecipitation assays revealed that overexpression of miR-26A1 could significantly induce the enrichment of H3K27ac at the enhancer regions in A549 cells. To sum up, our findings revealed that enhancer-mediated TSGs regulation occured in NSCLC, suggesting that miR-26A1 could serve as a key regulator and may be a potential therapeutic target for NSCLC. Oxford University Press 2022-08-03 /pmc/articles/PMC9838096/ /pubmed/35921230 http://dx.doi.org/10.1093/hmg/ddac185 Text en © The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Article
Li, Hongling
Da, Dezhuan
Yu, Wenqiang
Chen, Lu
Yang, Shuai
Zhang, Baolong
Wang, Yongying
Li, Linyu
Dang, Chunyan
Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLC
title Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLC
title_full Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLC
title_fullStr Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLC
title_full_unstemmed Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLC
title_short Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLC
title_sort tumor suppressor genes are reactivated by mir-26a1 via enhancer reprogramming in nsclc
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838096/
https://www.ncbi.nlm.nih.gov/pubmed/35921230
http://dx.doi.org/10.1093/hmg/ddac185
work_keys_str_mv AT lihongling tumorsuppressorgenesarereactivatedbymir26a1viaenhancerreprogramminginnsclc
AT dadezhuan tumorsuppressorgenesarereactivatedbymir26a1viaenhancerreprogramminginnsclc
AT yuwenqiang tumorsuppressorgenesarereactivatedbymir26a1viaenhancerreprogramminginnsclc
AT chenlu tumorsuppressorgenesarereactivatedbymir26a1viaenhancerreprogramminginnsclc
AT yangshuai tumorsuppressorgenesarereactivatedbymir26a1viaenhancerreprogramminginnsclc
AT zhangbaolong tumorsuppressorgenesarereactivatedbymir26a1viaenhancerreprogramminginnsclc
AT wangyongying tumorsuppressorgenesarereactivatedbymir26a1viaenhancerreprogramminginnsclc
AT lilinyu tumorsuppressorgenesarereactivatedbymir26a1viaenhancerreprogramminginnsclc
AT dangchunyan tumorsuppressorgenesarereactivatedbymir26a1viaenhancerreprogramminginnsclc